$XXII
22nd Century Group, Inc. Stock $xxii

$xxii Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024004163 Filed on March 28, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$6.469M	$32.20M	$32.20M
YoY Change	-70.54%	256.04%	-48.15%
Cost Of Revenue	$7.598M	$40.90M	$40.90M
YoY Change	-67.16%	106.03%	-32.88%
Gross Profit	-$1.129M	-$8.696M	-$8.696M
YoY Change	-4.08%	1248.22%	-840.72%
Gross Profit Margin	-17.45%	-27.0%	-27.0%
Selling, General & Admin	$2.906M	$30.88M	$30.88M
YoY Change	-79.58%	137.71%	-30.64%
% of Gross Profit
Research & Development	$425.0K	$2.000M	$2.000M
YoY Change	-71.98%	-1.86%	-69.52%
% of Gross Profit
Depreciation & Amortization	$266.0K	$521.0K	$3.951M
YoY Change	-34.96%	-39.84%	38.24%
% of Gross Profit
Operating Expenses	$3.305M	$33.58M	$33.58M
YoY Change	-80.15%	120.85%	-42.39%
Operating Profit	-$4.434M	-$42.27M	-$42.27M
YoY Change	-75.12%	166.73%	-25.97%
Interest Expense	$1.016M	-$9.147M	-$9.147M
YoY Change	141.33%	822.08%	-2691.22%
% of Operating Profit
Other Income/Expense, Net	-$1.016M	$334.0K	$334.0K
YoY Change	183.01%	370.42%	-110.67%
Pretax Income	-$5.450M	-$54.64M	-$54.64M
YoY Change	-70.03%	126.38%	-9.29%
Income Tax	$0.00	$47.00K	$47.00K
% Of Pretax Income
Net Earnings	-$5.739M	-$150.8M	-$150.8M
YoY Change	-68.44%	1590.59%	152.11%
Net Earnings / Revenue	-88.72%	-468.16%	-468.16%
Basic Earnings Per Share	-$2.94		-$7.28
Diluted Earnings Per Share	-$2.94	-$116.50	-$116.50
COMMON SHARES
Basic Shares Outstanding	55.72M	30.88M	20.71M
Diluted Shares Outstanding	3.165M		20.71M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.517M	$2.058M	$2.058M
YoY Change	-90.65%	-90.3%	-90.3%
Cash & Equivalents	$1.517M	$2.058M	$2.058M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$1.792M	$2.434M	$2.434M
YoY Change	-20.43%	-11.27%	-11.27%
Inventory	$2.889M	$4.346M	$4.346M
Prepaid Expenses
Receivables	$1.747M	$1.671M	$1.671M
Other Receivables	$5.768M	$5.768M	$5.768M
Total Short-Term Assets	$13.71M	$16.28M	$16.28M
YoY Change	-66.67%	-63.51%	-63.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.236M	$5.287M	$5.287M
YoY Change	-77.41%	-59.62%	-66.47%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles	$5.820M	$5.924M
YoY Change	-68.34%	-64.85%
Long-Term Investments
YoY Change
Other Assets	$15.00K	$15.00K	$15.00K
YoY Change	-99.59%	-99.58%	-99.58%
Total Long-Term Assets	$10.90M	$11.23M	$11.23M
YoY Change	-86.86%	-83.97%	-83.97%
TOTAL ASSETS
Total Short-Term Assets	$13.71M	$16.28M	$16.28M
Total Long-Term Assets	$10.90M	$11.23M	$11.23M
Total Assets	$24.62M	$27.50M	$27.50M
YoY Change	-80.17%	-76.01%	-76.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.046M	$4.445M	$4.445M
YoY Change	9.65%	6.65%	6.65%
Accrued Expenses	$1.449M	$8.438M	$8.438M
YoY Change	-77.02%	490.9%	25.36%
Deferred Revenue	$376.0K	$726.0K
YoY Change	46.3%	-12.64%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.577M	$6.391M	$6.391M
YoY Change	1994.59%	603.85%	603.85%
Total Short-Term Liabilities	$25.26M	$25.03M	$25.03M
YoY Change	49.76%	92.3%	92.3%
LONG-TERM LIABILITIES
Long-Term Debt	$8.136M	$8.058M	$8.058M
YoY Change	-50.44%	168.51%	168.51%
Other Long-Term Liabilities	$1.205M	$2.821M	$2.821M
YoY Change	-74.56%	446.71%	6.17%
Total Long-Term Liabilities	$9.341M	$10.88M	$10.88M
YoY Change	-55.84%	2008.33%	92.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.26M	$25.03M	$25.03M
Total Long-Term Liabilities	$9.341M	$10.88M	$10.88M
Total Liabilities	$36.24M	$35.91M	$35.91M
YoY Change	-15.29%	92.29%	92.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$384.4M	-$378.7M
YoY Change	50.11%	59.25%
Common Stock	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.62M	-$8.410M	-$8.410M
YoY Change
Total Liabilities & Shareholders Equity	$24.62M	$27.50M	$27.50M
YoY Change	-80.17%	-76.01%	-76.01%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$5.739M	-$150.8M	-$150.8M
YoY Change	-68.44%	1590.59%	152.11%
Depreciation, Depletion And Amortization	$266.0K	$521.0K	$3.951M
YoY Change	-34.96%	-39.84%	38.24%
Cash From Operating Activities	-$2.255M	-$4.807M	-$54.99M
YoY Change	-87.11%	-74.79%	6.33%
INVESTING ACTIVITIES
Capital Expenditures	$7.000K	$1.237M	$5.617M
YoY Change	-99.63%	-19.36%	53.6%
Acquisitions			$254.0K
YoY Change			-80.42%
Other Investing Activities	$22.00K	$693.0K	$22.43M
YoY Change	-99.87%	-97.08%	-16.94%
Cash From Investing Activities	$15.00K	-$534.0K	$16.82M
YoY Change	-99.9%	-102.41%	-25.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$36.78M
YoY Change			5.09%
Debt Paid & Issued, Net			$9.700M
YoY Change
Cash From Financing Activities	1.699M	-2.951M	37.21M
YoY Change	-90.67%	19.18%	20.73%
NET CHANGE
Cash From Operating Activities	-2.255M	-4.807M	-54.99M
Cash From Investing Activities	15.00K	-534.0K	16.82M
Cash From Financing Activities	1.699M	-2.951M	37.21M
Net Change In Cash	-541.0K	-8.292M	-962.0K
YoY Change	-103.51%	-1364.02%	-157.13%
FREE CASH FLOW
Cash From Operating Activities	-$2.255M	-$4.807M	-$54.99M
Capital Expenditures	$7.000K	$1.237M	$5.617M
Free Cash Flow	-$2.262M	-$6.044M	-$60.60M
YoY Change	-88.35%	-70.66%	9.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20711000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12856000
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001347858
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2023	us-gaap	Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43525862
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14349275
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-4.16
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.81
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.64
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.84
CY2023	xxii	Earnings Per Share Deemed Dividends Diluted EarningsPerShareDeemedDividendsDiluted	-0.48
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.65
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0667
CY2023	xxii	Maximum Maturity Date Of Securities MaximumMaturityDateOfSecurities	P24M
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Measurement Input Extensible List BusinessCombinationContingentConsiderationLiabilityMeasurementInputExtensibleList	http://fasb.org/us-gaap/2023#MeasurementInputDiscountRateMember
CY2023	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-36338
CY2023	dei	Entity Registrant Name EntityRegistrantName	22nd Century Group, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0468420
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	321 Farmington Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Mocksville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27028
CY2023	dei	City Area Code CityAreaCode	716
CY2023	dei	Local Phone Number LocalPhoneNumber	270-1523
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
CY2023	dei	Trading Symbol TradingSymbol	XXII
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	84000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55722442
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	317
CY2023	dei	Auditor Name AuditorName	Freed Maxick, CPAs, P.C.
CY2023	dei	Auditor Location AuditorLocation	Buffalo, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2058000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2205000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1123000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	344000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	4603000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	18193000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1671000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1363000
CY2023Q4	us-gaap	Inventory Net InventoryNet	4346000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7270000
CY2023Q4	xxii	Insurance Recoveries Current Assets InsuranceRecoveriesCurrentAssets	3768000
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	2000000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1180000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1928000
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1254000
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	13646000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	16277000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	44605000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3393000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3692000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1894000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	943000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5924000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7212000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3417000
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	54782000
CY2023Q4	us-gaap	Assets Assets	27503000
CY2022Q4	us-gaap	Assets Assets	114651000
CY2023Q4	xxii	Notes And Payables Current NotesAndPayablesCurrent	543000
CY2022Q4	xxii	Notes And Payables Current NotesAndPayablesCurrent	689000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5848000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	231000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	252000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4445000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2051000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1322000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	766000
CY2023Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	3768000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	883000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2662000
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2234000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1423000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	726000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	688000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1849000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	349000
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	3185000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	4138000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25034000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13018000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1698000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	711000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8058000
CY2023Q4	us-gaap	Liabilities Liabilities	35914000
CY2022Q4	us-gaap	Liabilities Liabilities	18676000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666667
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666667
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43525862
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14349275
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	370297000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	333900000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-111000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378707000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-237814000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8410000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	95975000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27503000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	114651000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32204000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40501000
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	40900000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	38654000
CY2023	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	-8696000
CY2022	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	1847000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31064000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32231000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2644000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3578000
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2527000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	327000
CY2023	us-gaap	Operating Expenses OperatingExpenses	36235000
CY2022	us-gaap	Operating Expenses OperatingExpenses	35482000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-44931000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-33635000
CY2022	xxii	Debt Securities Realized Gain Loss On Conversion DebtSecuritiesRealizedGainLossOnConversion	-2789000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	334000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-366000
CY2023	xxii	Gain Loss On Transfer Of Notes Receivable GainLossOnTransferOfNotesReceivable	-895000
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	219000
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	313000
CY2023	us-gaap	Interest Expense InterestExpense	9366000
CY2022	us-gaap	Interest Expense InterestExpense	55000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9708000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2897000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54639000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36532000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21000
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-54686000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-36553000
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-85634000
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-23703000
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	455000
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-455000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-86089000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-23248000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-140775000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59801000
CY2023	xxii	Deemed Dividends DeemedDividends	9992000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-150767000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-59801000
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.64
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.84
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-4.16
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.81
CY2023	xxii	Earnings Per Share Deemed Dividends Basic EarningsPerShareDeemedDividendsBasic	-0.48
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.65
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20711000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12856000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-140775000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59801000
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	71000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-316000
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-1000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	1000
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-41000
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-366000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	111000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	51000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-140664000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-59750000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	66074000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	174000
CY2022	xxii	Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes	-149000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	51653000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2516000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32484000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5489000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	51000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59801000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	95975000
CY2023	xxii	Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes	-419000
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	503000
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	3570000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2279000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22880000
CY2023	xxii	Warrant Exercises Stock Issuance Costs WarrantExercisesStockIssuanceCosts	292000
CY2023	xxii	Stock Issued During Period Value Warrants Exercise StockIssuedDuringPeriodValueWarrantsExercise	3044000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1577000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2679000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	111000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-140775000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8410000
CY2023	us-gaap	Profit Loss ProfitLoss	-140775000
CY2022	us-gaap	Profit Loss ProfitLoss	-59801000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	3297000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1488000
CY2023	xxii	Amortization And Depreciation Excluding Amortization Of Intangibles AmortizationAndDepreciationExcludingAmortizationOfIntangibles	3951000
CY2022	xxii	Amortization And Depreciation Excluding Amortization Of Intangibles AmortizationAndDepreciationExcludingAmortizationOfIntangibles	2858000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	908000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	733000
CY2022	xxii	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	978000
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-5000
CY2022	xxii	Unusual Or Infrequent Item Or Both Assets Write Offs UnusualOrInfrequentItemOrBothAssetsWriteOffs	4549000
CY2023	xxii	Other Noncash Gain Loss OtherNoncashGainLoss	15000
CY2022	xxii	Other Noncash Gain Loss OtherNoncashGainLoss	-563000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1024000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	770000
CY2023	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	-73000
CY2022	xxii	Gain Loss On Sale Of Property Plant And Equipment Nonoperating GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating	368000
CY2022	xxii	Debt Securities Realized Gain Loss On Conversion DebtSecuritiesRealizedGainLossOnConversion	-2789000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	237000
CY2023	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	8006000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2679000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5489000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1138000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-364000
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	557000
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-58521000
CY2023	xxii	Gain Loss On Transfer Of Notes Receivable GainLossOnTransferOfNotesReceivable	-895000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	434000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-434000
CY2023	xxii	Increase In Inventory Reserves IncreaseInInventoryReserves	8695000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2881000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5925000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8789000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-451000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	920000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4752000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	416000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	681000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-582000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2153000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	748000
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	811000
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	153000
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-334000
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	285000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54987000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51714000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	961000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	772000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4656000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3657000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	283000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	409000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	254000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1297000
CY2023	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	665000
CY2022	xxii	Payments To Acquire Investment Including Receivable And Equity Securities PaymentsToAcquireInvestmentIncludingReceivableAndEquitySecurities	682000
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	3500000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	21714000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment	101990000
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3475000
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	73413000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16816000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	22578000
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5581000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3822000
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	2360000
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	2162000
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-29000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9700000
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	16849000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	801000
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	6016000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	174000
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3044000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	420000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	149000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37209000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30820000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-962000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1684000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3020000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1336000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2058000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3020000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1313000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	34000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	40000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	118000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	94000
CY2023	xxii	Right Of Use Assets And Corresponding Operating Lease Obligations RightOfUseAssetsAndCorrespondingOperatingLeaseObligations	5166000
CY2023	xxii	Noncash Assignment Of Promissory Note NoncashAssignmentOfPromissoryNote	2600000
CY2023	xxii	Noncash Insurance And Litigation Amount NoncashInsuranceAndLitigationAmount	3768000
CY2023	xxii	Non Cash Proceeds From Sale Of Discontinued Operations NonCashProceedsFromSaleOfDiscontinuedOperations	2000000
CY2023	xxii	Deemed Dividends Non Cash DeemedDividendsNonCash	9801000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	51653000
CY2023	xxii	Non Cash Consideration On Acquisition NonCashConsiderationOnAcquisition	1641000
CY2023	xxii	Non Cash Licensing Arrangement NonCashLicensingArrangement	-3500000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span>–<b style="font-weight:bold;"> </b>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54987000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51714000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378707000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-237814000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2058000
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	165000
CY2023	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	true
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	66035
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risk </span>– Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institutions. Although the cash accounts exceed the federally insured deposit amount, management does not anticipate nonperformance by the financial institutions. Management reviews the financial viability of these institutions on a periodic basis.</p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2023Q4	us-gaap	Goodwill Goodwill	0
CY2023	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	3029000
CY2023	xxii	Deemed Dividend Related To Incremental Value Of Replacement Warrants DeemedDividendRelatedToIncrementalValueOfReplacementWarrants	6596000
CY2023	xxii	Deemed Dividend Related To Down Round Provisions And Anti Dilution Provisions DeemedDividendRelatedToDownRoundProvisionsAndAntiDilutionProvisions	367000
CY2023	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Embedded Derivatives</span><i style="font-style:italic;"> - </i>The Company considers whether there are any embedded features in debt instruments that require bifurcation and separate accounting as derivative financial instruments pursuant to ASC 815. Embedded derivatives are initially and subsequently measured at fair value. With the exception of the bifurcated embedded conversion option as described in Note 13 “Debt”, the embedded derivatives associated with the Company’s Senior Secured Credit Facility and Subordinated Note are not material.</p>
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	238000
CY2022	xxii	Accrued Liabilities Accruals AccruedLiabilitiesAccruals	692000
CY2022	xxii	Accrued Liabilities Cash Payments AccruedLiabilitiesCashPayments	-296000
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	634000
CY2023	xxii	Accrued Liabilities Accruals AccruedLiabilitiesAccruals	790000
CY2023	xxii	Reversal From Settlement ReversalFromSettlement	-168000
CY2023	xxii	Accrued Liabilities Cash Payments AccruedLiabilitiesCashPayments	-870000
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	386000
CY2023Q4	xxii	Current Severance Accrual CurrentSeveranceAccrual	386000
CY2022Q4	xxii	Current Severance Accrual CurrentSeveranceAccrual	349000
CY2022Q4	xxii	Noncurrent Severance Accrual NoncurrentSeveranceAccrual	285000
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	386000
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	634000
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	622000
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	692000
CY2023Q1	xxii	Business Combination Number Of Novel Food Applications BusinessCombinationNumberOfNovelFoodApplications	1276
CY2023Q1	xxii	Business Combination Contingent Consideration Liability Maximum Payout BusinessCombinationContingentConsiderationLiabilityMaximumPayout	1550000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1138000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Measurement Input BusinessCombinationContingentConsiderationLiabilityMeasurementInput	16
CY2023Q3	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	53000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1138000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3580000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	7090000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	766000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	177000
CY2023Q4	us-gaap	Inventory Net InventoryNet	4346000
CY2022Q4	us-gaap	Inventory Net InventoryNet	7270000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7770000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7426000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4377000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3734000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3393000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3692000
CY2023	us-gaap	Depreciation Depreciation	852000
CY2022	us-gaap	Depreciation Depreciation	673000
CY2023Q1	xxii	Lessee Operating Lease Monthly Base Rent LesseeOperatingLeaseMonthlyBaseRent	15000
CY2023Q1	xxii	Lessee Operating Lease Annual Increase In Base Rent As Percent LesseeOperatingLeaseAnnualIncreaseInBaseRentAsPercent	0.030
CY2023Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P36M
CY2023Q1	xxii	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P24M
CY2023Q1	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.090
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	396000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	403000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	422000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	430000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	449000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	414000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2514000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	585000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1929000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	231000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1698000
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	475000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	288000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	436000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	276000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1602000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7078000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3288000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	552000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3238000
CY2023Q4	xxii	Indefinite Lived Intangible Assets Cost IndefiniteLivedIntangibleAssetsCost	2686000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2686000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	9764000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3288000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	552000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5924000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9524000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5005000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4519000
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2693000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7212000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	655000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	619000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1375000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	35000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	422000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	410000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	351000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	365000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	321000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	1369000
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3800000
CY2023Q4	xxii	Extinguishment Of Discount On Note Receivable ExtinguishmentOfDiscountOnNoteReceivable	305000
CY2023Q4	xxii	Noncash Assignment Of Promissory Note NoncashAssignmentOfPromissoryNote	2600000
CY2023Q4	xxii	Gain Loss On Transfer Of Notes Receivable GainLossOnTransferOfNotesReceivable	895000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	7143000
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	7031000
CY2023	us-gaap	Interest Income Short Term Investment Other InterestIncomeShortTermInvestmentOther	52000
CY2022	us-gaap	Interest Income Short Term Investment Other InterestIncomeShortTermInvestmentOther	546000
CY2022	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	1138212
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1138212
CY2023	xxii	Number Of Warrants Exercised NumberOfWarrantsExercised	18084052
CY2023	xxii	Number Of Warrants Abandoned NumberOfWarrantsAbandoned	325205
CY2023	xxii	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	65028421
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	47757376
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	47757376
CY2023Q4	xxii	Number Of Warrants Repriced NumberOfWarrantsRepriced	747974
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	390247
CY2023Q4	xxii	Aggregate Number Of Pre Funded Warrants In Percentage AggregateNumberOfPreFundedWarrantsInPercentage	0.10
CY2023Q4	xxii	Percentage Of Public Offering Accompanying Common Warrant PercentageOfPublicOfferingAccompanyingCommonWarrant	1.25
CY2023Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5250000
CY2023Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	367000
CY2023Q4	us-gaap	Other General Expense OtherGeneralExpense	288000
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1765
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	166667
CY2023Q4	xxii	Warrant Aggregate Put Price WarrantAggregatePutPrice	2500000
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.03
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	231000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	198000
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	689000
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	374000
CY2023Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	350000
CY2023Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	100000
CY2023Q4	xxii	Contractual Obligation Due After Fourth Year ContractualObligationDueAfterFourthYear	3575000
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	5088000
CY2019Q4	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	3
CY2023Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	3000000
CY2020Q1	us-gaap	Loss Contingency Pending Claims Number LossContingencyPendingClaimsNumber	3
CY2023Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	768000
CY2022Q4	us-gaap	Unusual Or Infrequent Item Insurance Proceeds UnusualOrInfrequentItemInsuranceProceeds	5000000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1453000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	13906000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5848000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8058000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	7500000
CY2023Q4	xxii	Revenue Debentures Agreement Amount RevenueDebenturesAgreementAmount	18500000
CY2023Q4	xxii	Amended Revenue Debentures Agreement Amount AmendedRevenueDebenturesAgreementAmount	15500000
CY2023Q4	xxii	Amount Required In Escrow Fund AmountRequiredInEscrowFund	7500000
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3800000
CY2023Q4	xxii	Pledged Indebtedness Nonmonetary Transaction PledgedIndebtednessNonmonetaryTransaction	2600000
CY2023Q4	xxii	Reduction Of Put Price Amount ReductionOfPutPriceAmount	2000000
CY2023Q4	xxii	Balance Reduction Of Debentures BalanceReductionOfDebentures	600000
CY2023Q4	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	895000
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	166667
CY2023Q4	xxii	Warrant Aggregate Put Price WarrantAggregatePutPrice	2500000
CY2023Q4	xxii	Reduction Of Put Price Amount ReductionOfPutPriceAmount	2000000
CY2023Q4	us-gaap	Notes Reduction NotesReduction	500000
CY2023Q4	xxii	Debt Instrument Redemption Amount DebtInstrumentRedemptionAmount	2200000
CY2023Q4	xxii	Payment Made By Company To Reduce PaymentMadeByCompanyToReduce	1100000
CY2023Q4	xxii	Payment Made By Buyer To Reduce Debt PaymentMadeByBuyerToReduceDebt	1100000
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12
CY2023Q4	us-gaap	Unusual Or Infrequent Item Insurance Proceeds UnusualOrInfrequentItemInsuranceProceeds	1000000
CY2023Q4	xxii	Threshold Limit For Insurance Proceeds ThresholdLimitForInsuranceProceeds	5000000
CY2023Q4	xxii	Area Of Real Estate Property Closed AreaOfRealEstatePropertyClosed	224
CY2023Q4	xxii	Additional Debt Reduction AdditionalDebtReduction	1000000
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.00
CY2023Q4	xxii	Debt Instrument Redemption Price Percentage Of Net Cash Proceeds Percent DebtInstrumentRedemptionPricePercentageOfNetCashProceedsPercent	0.20
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5158000
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	557000
CY2023Q4	xxii	Warrants Fair Value Disclosure WarrantsFairValueDisclosure	5791000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1053000
CY2023Q4	xxii	Debenture Exit Payments DebentureExitPayments	1053000
CY2023Q4	xxii	Debt Instrument Third Party Debt Issuance Costs DebtInstrumentThirdPartyDebtIssuanceCosts	801000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8698000
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-2087000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5158000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1453000
CY2023Q4	xxii	Insurance Loans Payable Current InsuranceLoansPayableCurrent	543000
CY2022Q4	xxii	Insurance Loans Payable Current InsuranceLoansPayableCurrent	689000
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	543000
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	689000
CY2023Q2	xxii	Directors And Officers Insurance Policy Term DirectorsAndOfficersInsurancePolicyTerm	P1Y
CY2023Q2	xxii	Directors And Officers Insurance Premium DirectorsAndOfficersInsurancePremium	1626000
CY2023Q2	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	285000
CY2023Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1341000
CY2023Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10M
CY2023Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0788
CY2023Q3	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	143000
CY2023Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0938
CY2023Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2022Q2	xxii	Directors And Officers Insurance Policy Term DirectorsAndOfficersInsurancePolicyTerm	P1Y
CY2022Q2	xxii	Directors And Officers Insurance Premium DirectorsAndOfficersInsurancePremium	2394000
CY2022Q2	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	400000
CY2022Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1994000
CY2022Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10M
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325
CY2022Q3	xxii	Directors And Officers Insurance Premium Paid DirectorsAndOfficersInsurancePremiumPaid	90000
CY2022Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	168000
CY2022Q3	xxii	Directors And Officers Insurance Policy Term DirectorsAndOfficersInsurancePolicyTerm	P1Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	333334
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	233334
CY2021Q2	xxii	Share Based Compensation Arrangement Plan Term ShareBasedCompensationArrangementPlanTerm	P10Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	606406
CY2023	xxii	Employee Benefits And Share Based Compensation Continuing Operations EmployeeBenefitsAndShareBasedCompensationContinuingOperations	2231000
CY2022	xxii	Employee Benefits And Share Based Compensation Continuing Operations EmployeeBenefitsAndShareBasedCompensationContinuingOperations	5434000
CY2023	xxii	Employee Benefits And Share Based Compensation Discontinuing Operations EmployeeBenefitsAndShareBasedCompensationDiscontinuingOperations	448000
CY2022	xxii	Employee Benefits And Share Based Compensation Discontinuing Operations EmployeeBenefitsAndShareBasedCompensationDiscontinuingOperations	55000
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2679000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	5489000
CY2023	xxii	Equity Based Compensation Expense Reversals Employee Termination Forfeitures EquityBasedCompensationExpenseReversalsEmployeeTerminationForfeitures	1960000
CY2022	xxii	Equity Based Compensation Expense Reversals Employee Termination Forfeitures EquityBasedCompensationExpenseReversalsEmployeeTerminationForfeitures	84000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	523000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1237000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	211000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	37.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	236000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	29.40
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	154000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	31.65
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	24000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	35.85
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	269000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.88
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	293000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	12.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	147000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	29.67
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	260000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	20.86
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	155000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1838000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	4505000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	345000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.75
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.40
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	20.85
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	41.40
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	327000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.82
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	101000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	21.29
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	7000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	41.40
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	219000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.34
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	213000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	25.95
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M18D
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-54686000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-36553000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-86089000
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-23248000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-140775000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-59801000
CY2023	xxii	Deemed Dividends DeemedDividends	9992000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-150767000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-59801000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20711000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12856000
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.64
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.84
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-4.16
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.81
CY2023	xxii	Earnings Per Share Deemed Dividends Basic EarningsPerShareDeemedDividendsBasic	-0.48
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.65
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	48131000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1734000
CY2022	xxii	Allowance Amount For Discounts Or Returns And Allowances AllowanceAmountForDiscountsOrReturnsAndAllowances	0
CY2023	xxii	Allowance Amount For Discounts Or Returns And Allowances AllowanceAmountForDiscountsOrReturnsAndAllowances	0
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	10413000
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	12619000
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1053000
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	354000
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	178000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	726000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	688000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	119000
CY2023Q4	xxii	Contract Asset Liability Net ContractAssetLiabilityNet	327000
CY2022Q4	xxii	Contract Asset Liability Net ContractAssetLiabilityNet	-334000
CY2021Q4	xxii	Contract Asset Liability Net ContractAssetLiabilityNet	59000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	688000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	119000
CY2023	xxii	Impairments Of Intangible Assets Excluding Goodwill ImpairmentsOfIntangibleAssetsExcludingGoodwill	1375000
CY2022	xxii	Impairments Of Intangible Assets Excluding Goodwill ImpairmentsOfIntangibleAssetsExcludingGoodwill	35000
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	56000
CY2023	xxii	Professional Fees Under Restructuring ProfessionalFeesUnderRestructuring	763000
CY2023	xxii	Severance Costs Under Restructuring SeveranceCostsUnderRestructuring	221000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	2415000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	35000
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	223000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	111000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	362000
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2527000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	327000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	2415000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	40000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	14000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	14000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-11351000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6610000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-736000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4404000
CY2023	xxii	Total Deferred Benefit Related To Income Taxes TotalDeferredBenefitRelatedToIncomeTaxes	-12087000
CY2022	xxii	Total Deferred Benefit Related To Income Taxes TotalDeferredBenefitRelatedToIncomeTaxes	-11014000
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	12094000
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	11021000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	-0.008
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.013
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.004
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.120
CY2023	xxii	Effective Income Tax Rate Reconciliation Section162 M Limitation Percent EffectiveIncomeTaxRateReconciliationSection162MLimitationPercent	0.002
CY2022	xxii	Effective Income Tax Rate Reconciliation Section162 M Limitation Percent EffectiveIncomeTaxRateReconciliationSection162MLimitationPercent	0.009
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.220
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.301
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	0
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7357000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	54453000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34029000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2020000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	220000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	862000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1144000
CY2023Q4	xxii	Deferred Tax Liabilities Start Up Expenditures DeferredTaxLiabilitiesStartUpExpenditures	155000
CY2022Q4	xxii	Deferred Tax Liabilities Start Up Expenditures DeferredTaxLiabilitiesStartUpExpenditures	175000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1424000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1205000
CY2023Q4	xxii	Deferred Tax Assets Accrued Bonus DeferredTaxAssetsAccruedBonus	133000
CY2022Q4	xxii	Deferred Tax Assets Accrued Bonus DeferredTaxAssetsAccruedBonus	458000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	95000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Severance Payments DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsSeverancePayments	151000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	2000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1617000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	813000
CY2023Q4	xxii	Deferred Tax Assets Operating Lease Obligations DeferredTaxAssetsOperatingLeaseObligations	476000
CY2022Q4	xxii	Deferred Tax Assets Operating Lease Obligations DeferredTaxAssetsOperatingLeaseObligations	229000
CY2023Q4	xxii	Deferred Tax Assets Capital Loss On Investment DeferredTaxAssetsCapitalLossOnInvestment	2449000
CY2022Q4	xxii	Deferred Tax Assets Capital Loss On Investment DeferredTaxAssetsCapitalLossOnInvestment	2209000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements	581000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1758000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	50000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	66025000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40683000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	283000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	221000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	193000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	203000
CY2023Q4	xxii	Deferred Tax Liabilities Operating Lease Righ Tof Use Asset DeferredTaxLiabilitiesOperatingLeaseRighTofUseAsset	467000
CY2022Q4	xxii	Deferred Tax Liabilities Operating Lease Righ Tof Use Asset DeferredTaxLiabilitiesOperatingLeaseRighTofUseAsset	225000
CY2023Q4	xxii	Deferred Tax Liabilities Other Intangible Assets DeferredTaxLiabilitiesOtherIntangibleAssets	385000
CY2022Q4	xxii	Deferred Tax Liabilities Other Intangible Assets DeferredTaxLiabilitiesOtherIntangibleAssets	334000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1328000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	983000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	64763000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	39759000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	66000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	59000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	193322000
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	46920000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1424000
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9932000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12094000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	11021000
CY2023	xxii	Disposal Group Including Discontinued Operation Valuation Allowance Deferred Tax Asset Increase Decrease Amount DisposalGroupIncludingDiscontinuedOperationValuationAllowanceDeferredTaxAssetIncreaseDecreaseAmount	12910000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7871000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8050000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8926000
CY2023Q4	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	-7829000
CY2023Q3	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	77000
CY2023Q2	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	-961000
CY2023Q1	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	17000
CY2023Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-22068000
CY2023Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8081000
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13707000
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10830000
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.66
CY2023Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.66
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.41
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.41
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.92
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.92
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.75
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.75
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9951000
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11535000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9970000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9045000
CY2022Q4	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	-44000
CY2022Q3	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	636000
CY2022Q2	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	928000
CY2022Q1	xxii	Gross Profit Excluding Depreciation GrossProfitExcludingDepreciation	328000
CY2022Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11114000
CY2022Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10490000
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7699000
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7250000
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.77
CY2022Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.77
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.75
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.75
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.63
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.63
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.67
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.67
CY2023	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	7720000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5158000

Files In Submission

Name	View Source	Status
0001558370-24-004163-index-headers.html	Edgar Link	pending
0001558370-24-004163-index.html	Edgar Link	pending
0001558370-24-004163.txt	Edgar Link	pending
0001558370-24-004163-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xxii-20231231.xsd	Edgar Link	pending
xxii-20231231x10k.htm	Edgar Link	pending
xxii-20231231xex19d1.htm	Edgar Link	pending
xxii-20231231xex21d1.htm	Edgar Link	pending
xxii-20231231xex23d1.htm	Edgar Link	pending
xxii-20231231xex31d1.htm	Edgar Link	pending
xxii-20231231xex31d2.htm	Edgar Link	pending
xxii-20231231xex32d1.htm	Edgar Link	pending
xxii-20231231xex4d1.htm	Edgar Link	pending
xxii-20231231xex97d1.htm	Edgar Link	pending
xxii-20231231_def.xml	Edgar Link	unprocessable
xxii-20231231_lab.xml	Edgar Link	unprocessable
xxii-20231231_pre.xml	Edgar Link	unprocessable
xxii-20231231x10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
xxii-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XXII
22nd Century Group, Inc. Stock $xxii

2024 Q1 Form 10-K Financial Statement

#000155837024004163 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII 22nd Century Group, Inc. Stock $xxii

2024 Q1 Form 10-K Financial Statement

#000155837024004163 Filed on March 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XXII
22nd Century Group, Inc. Stock $xxii